|Basic InformationLookupsLatest News|A Shot of Caffeine May Speed Wake-Up After AnesthesiaZika Hijacks Pregnant Woman's Immune SystemHernia Patients May Need Fewer Opioids After Surgery, Study FindsHealth Tip: Prevent DehydrationTravel Tips for Contact Lens WearersHigher Odds of Infection With Reduced Kidney FunctionMost Ulcerative Colitis Patients Do Not Achieve Target RemissionOral Contraceptive Use Linked to Lower Rheumatoid Arthritis RiskKidney Disease May Boost Odds of InfectionZika May Not Last in Semen as Long as ThoughtVirtual House Calls for Speedy, Effective Parkinson's CareNearly 4 Million Worldwide Die Each Year From Asthma, COPDPowerful New Cholesterol Med Won't Harm Memory, Easing ConcernsDiverse Spectrum of Neurologic Syndromes Seen With ZikaExposure to Particulate Matter Linked to Metabolic AlterationsAir Purifiers May Help the Smog-Stressed Heart'Fat But Fit' a Myth?Statin Use Among Nursing Home Residents Varies SignificantlyZika Virus Tied to Neurological Woes in AdultsAn Expert's Guide to Preventing Food PoisoningHeart Risk Up if Hospitalized for Pneumonia or SepsisSinging May Be Good Medicine for Parkinson's PatientsCPAP Doesn't Alter Renal Function in Coexisting OSA, CVDWhen Stress Hormone Falters, Your Health May SufferKidney Disease May Boost Risk of Abnormal HeartbeatCertain Jobs Linked to Raised Risk of Rheumatoid ArthritisMidlife Vascular Risk Factors Tied to Increased Risk of DementiaHigher Risk of CVD Persists After Hospital Stay for Severe InfectionAntibiotic Doesn't Prevent Lung Complication After Stem Cell TransplantHealth Tip: One of Three Adults Gets ShinglesBlood Pressure Fluctuations Tied to Dementia Risk in StudyDecline in Kids' Ear Infections Linked to Pneumococcal VaccineFDA Approves Mavyret for Hepatitis CDoes Less Sleep Make You Less Healthy?Diabetes Drug Shows Promise Against Parkinson'sReview Suggests Benefits of Aerobic Exercise in FibromyalgiaNovel Procedure Improves Kidney Transplant SuccessABP 501, Adalimumab Biosimilar, Safe and Effective, for PsoriasisSimilar Defects ID'd for T2DM, Chronic Pancreatitis and DiabetesScientists Gain Insight Into AllergiesHealth Tip: Cooling a Heat RashKnow the Signs of ConcussionDo Your Pearly Whites Sometimes Cause You Pain?Rates of Inflammatory Bowel Disease Down in Rural AreasZika Probably Not Spread Through Saliva: StudyDrug for Kidney Disease Tied to Infection RiskGum Disease May Be Linked to Cancer Risk in Older WomenStent Surgery Could Benefit Select Glaucoma PatientsBlood Proteins Linked to Severity of Chronic Fatigue SyndromeDrowning Can Occur Hours After SwimmingQuestions and AnswersLinksBook Reviews
Xanax, Valium May Boost Pneumonia Risk in Alzheimer's Patients
by -- Robert Preidt
Updated: Apr 10th 2017
MONDAY, April 10, 2017 (HealthDay News) -- Alzheimer's patients given sedatives such as Valium or Xanax may have an increased risk for pneumonia, a new study warns.
People with Alzheimer's disease are often given these drugs, called benzodiazepines, over the long term, the researchers said.
Examples of benzodiazepines include alprazolam (Xanax), clonazepam (Klonopin), diazepam (Valium), and lorazepam (Ativan).
"An increased risk of pneumonia is an important finding to consider in treatment of patients with Alzheimer disease. Pneumonia often leads to admission to hospital, and patients with dementia are at increased risk of death related to pneumonia," Dr. Heidi Taipale, of Kuopio Research Center of Geriatric Care at the University of Eastern Finland, and co-authors wrote.
For the study, the researchers reviewed data from nearly 50,000 Alzheimer's patients in Finland. The patients' average age was 80 and about two-thirds were women.
The study found that people with Alzheimer's who took benzodiazepines were 30 percent more likely to develop pneumonia than those who weren't given the sedatives.
The risk of pneumonia was highest in the first 30 days after starting the drugs, the findings showed.
The researchers said their findings are consistent with previous studies.
Because benzodiazepines are sedating, it's possible that people taking them may breathe saliva or food into the lungs, increasing the risk of pneumonia, the study authors suggested.
Taipale's team said the benefits and risks of these drugs -- including pneumonia -- need to be carefully considered before giving them to someone with Alzheimer's disease.
The study was published April 10 in the CMAJ (Canadian Medical Association Journal).
The study is "a good reminder to clinicians to 'first do no harm' when prescribing these drugs for frail older women and men with dementia," Dr. Paula Rochon and her co-authors wrote in an accompanying editorial in the journal. Rochon is from Women's College Hospital and the University of Toronto.
Non-drug "approaches should be the starting point when managing neuropsychiatric symptoms in this patient population, which should help to limit inappropriate use of these drugs," the editorial authors said.
The U.S. National Institute on Aging has more about Alzheimer's disease.
This article: Copyright © 2017 HealthDay. All rights reserved.